Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Genes, erbB-2"" wg kryterium: Temat


Tytuł:
Validation of Dual-Color Dual In Situ Hybridization for HER2/neu Gene in Breast Cancer.
Autorzy:
Rathi A; From the Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Sahay A; From the Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Shet TM; From the Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Patil A; From the Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Desai SB; From the Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Apr 01; Vol. 148 (4), pp. 453-460.
Typ publikacji:
Journal Article
MeSH Terms:
Genes, erbB-2*
Breast Neoplasms*/diagnosis
Humans ; Female ; In Situ Hybridization, Fluorescence/methods ; Reproducibility of Results ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Immunohistochemistry
Czasopismo naukowe
Tytuł:
A gene expression-based classifier for HER2-low breast cancer.
Autorzy:
Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Pizzamiglio S; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy. .
Ciniselli CM; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Duroni V; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Cappelletti V; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
De Cecco L; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
De Marco C; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Silvestri M; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
De Santis MC; Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Breast Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Vingiani A; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Breast Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Paolini B; Department of Pathology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Orlandi R; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Iorio MV; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Pruneri G; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Breast Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Verderio P; Bioinformatics and Biostatistics Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 01; Vol. 14 (1), pp. 2628. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/genetics
Humans ; Female ; Receptor, ErbB-2/metabolism ; Genes, erbB-2 ; Immunohistochemistry ; Gene Expression ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism
Czasopismo naukowe
Tytuł:
In Vitro and In Vivo Effects of the Combination of Polypurine Reverse Hoogsteen Hairpins against HER-2 and Trastuzumab in Breast Cancer Cells.
Autorzy:
López-Aguilar E; Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Universitat de Barcelona (UB), 08028 Barcelona, Spain.
Fernández-Nogueira P; Unit of Biophysics and Bioengineering, Department of Biomedicine, School of Medicine and Health Sciences, Universitat de Barcelona (UB), 08028 Barcelona, Spain.; Department of Biochemistry and Molecular Biomedicine, School of Biology, Universitat de Barcelona (UB), 08028 Barcelona, Spain.
Fuster G; Department of Biochemistry and Molecular Biomedicine, School of Biology, Universitat de Barcelona (UB), 08028 Barcelona, Spain.; Tissue Repair and Regeneration Laboratory (TR2Lab), Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IrisCC), 08500 Vic, Spain.; Department of Biosciences, Faculty of Sciences, Technology and Engineering, Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), 08500 Vic, Spain.; Institute of Biomedicine, Universitat de Barcelona (IBUB), 08028 Barcelona, Spain.
Carbó N; Department of Biochemistry and Molecular Biomedicine, School of Biology, Universitat de Barcelona (UB), 08028 Barcelona, Spain.; Institute of Biomedicine, Universitat de Barcelona (IBUB), 08028 Barcelona, Spain.
Ciudad CJ; Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Universitat de Barcelona (UB), 08028 Barcelona, Spain.; Institute of Nanoscience and Nanotechnology, Universitat de Barcelona (IN2UB), 08028 Barcelona, Spain.
Noé V; Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Universitat de Barcelona (UB), 08028 Barcelona, Spain.; Institute of Nanoscience and Nanotechnology, Universitat de Barcelona (IN2UB), 08028 Barcelona, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Apr 11; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 11.
Typ publikacji:
Journal Article
MeSH Terms:
Genes, erbB-2*
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/metabolism
Humans ; Female ; Trastuzumab/pharmacology ; Trastuzumab/genetics ; Oncogenes ; MCF-7 Cells ; RNA, Messenger/genetics ; Cell Line, Tumor ; Receptor, ErbB-2/genetics
Czasopismo naukowe
Tytuł:
HER2 testing by immunohistochemistry in breast cancer: A multicenter proficiency ring study.
Autorzy:
Md Pauzi SH; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
Masir N; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
Yahaya A; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
Mohammed F; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
Tizen Laim NMS; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
Mustangin M; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
Aizudin AN; Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
Talib A; Department of Pathology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
Teoh KH; Department of Pathology, University Malaya Medical Centre, Lembah Pantai, Kuala Lumpur, Kuala Lumpur.
Karim N; Department of Pathology, Hospital Raja Permaisuri Bainun, 30450 Ipoh, Perak, Malaysia.
Oy-Leng JW; Department of Pathology, Sarawak General Hospital, 93586 Kuching, Sarawak, Malaysia.
Rajadurai P; Subang Jaya Medical Centre, 47500 Subang Jaya, Selangor, Malaysia.
Pokaż więcej
Źródło:
Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2021 Oct-Dec; Vol. 64 (4), pp. 677-682.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study
MeSH Terms:
Genes, erbB-2*
Breast Neoplasms/*genetics
Breast Neoplasms/*metabolism
Carcinoma/*genetics
Carcinoma/*metabolism
Immunohistochemistry/*statistics & numerical data
Receptor, ErbB-2/*metabolism
Adult ; Aged ; Aged, 80 and over ; Female ; Genetic Variation ; Humans ; Immunohistochemistry/methods ; Middle Aged ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes.
Autorzy:
Uckun FM; Immuno-Oncology Program, Ares Pharmaceuticals, St. Paul, MN 55110, USA.
Qazi S; Immuno-Oncology Program, Ares Pharmaceuticals, St. Paul, MN 55110, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 09; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 09.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Myeloma*/genetics
Breast Neoplasms*/genetics
Humans ; Female ; Genes, erbB-2 ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Treatment Outcome ; Base Sequence
Czasopismo naukowe
Tytuł:
Antimetastatic and Antitumor Activities of Orally Administered NAX014 Compound in a Murine Model of HER2-Positive Breast Cancer.
Autorzy:
Pierpaoli E; Advanced Technology Center for Aging Research, Scientific Technological Area, IRCCS INRCA, 60121 Ancona, Italy.
Piacenza F; Advanced Technology Center for Aging Research, Scientific Technological Area, IRCCS INRCA, 60121 Ancona, Italy.
Fiorillo G; Naxospharma Srl, 20026 Novate Milanese, Italy.
Lombardi P; Naxospharma Srl, 20026 Novate Milanese, Italy.
Orlando F; Experimental Animal Models for Aging Unit, Scientific Technological Area, IRCCS INRCA, 60121 Ancona, Italy.
Salvatore C; Aesis Therapeutics Srl, Incubatore JCube, 60035 Jesi, Italy.
Geroni C; Aesis Therapeutics Srl, Incubatore JCube, 60035 Jesi, Italy.
Provinciali M; Advanced Technology Center for Aging Research, Scientific Technological Area, IRCCS INRCA, 60121 Ancona, Italy.; Experimental Animal Models for Aging Unit, Scientific Technological Area, IRCCS INRCA, 60121 Ancona, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Mar 06; Vol. 22 (5). Date of Electronic Publication: 2021 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Genes, erbB-2*
Antineoplastic Agents/*therapeutic use
Berberine Alkaloids/*therapeutic use
Mammary Neoplasms, Experimental/*prevention & control
Neoplasm Metastasis/*prevention & control
Administration, Oral ; Animals ; Antineoplastic Agents/administration & dosage ; Berberine Alkaloids/administration & dosage ; Berberine Alkaloids/chemistry ; Cell Cycle Checkpoints/drug effects ; Cell Line, Tumor ; Cell Movement/drug effects ; Drug Screening Assays, Antitumor ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Mammary Neoplasms, Experimental/drug therapy ; Mammary Neoplasms, Experimental/genetics ; Mice ; Mice, Transgenic ; Molecular Structure ; Neoplasm Metastasis/drug therapy ; Neoplasm Proteins/biosynthesis ; Neoplasm Proteins/genetics ; Rats ; Tumor Burden/drug effects
Czasopismo naukowe
Tytuł:
Establishment and evaluation of digital PCR methods for HER2 copy number variation in breast cancer.
Autorzy:
Wang X; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
Xing D; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
Liu Z; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
Zhang Y; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China.
Cheng B; Chinese People's Liberation Army Rocket Force Characteristic Medical Center, Beijing, China.
Sun S; Chinese People's Liberation Army Rocket Force Characteristic Medical Center, Beijing, China.
Wang Q; Beijing Chaoyang Hospital, the Third Clinical Medical College of Capital Medical University, Beijing, China.
Dong L; Center for Advanced Measurement Science, National Institute of Metrology, Beijing, China. .
Pokaż więcej
Źródło:
Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2023 Feb; Vol. 415 (4), pp. 725-733. Date of Electronic Publication: 2022 Dec 26.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/pathology
Humans ; Female ; DNA Copy Number Variations ; In Situ Hybridization, Fluorescence ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Polymerase Chain Reaction/methods ; Genes, erbB-2
Czasopismo naukowe
Tytuł:
HER2 gene assessment in liquid biopsy of gastric and esophagogastric junction cancer patients qualified for surgery.
Autorzy:
Grenda A; Chair and Department of Pneumology, Oncology and Allergology, Medical University of Lublin, Jaczewskiego 8, 20-090, Lublin, Poland. .
Wojas-Krawczyk K; Chair and Department of Pneumology, Oncology and Allergology, Medical University of Lublin, Jaczewskiego 8, 20-090, Lublin, Poland.
Skoczylas T; II Chair and Department of General and Gastrointestinal Surgery and Surgical Oncology of the Alimentary Tract, Medical University of Lublin, Staszica 16, 20-080, Lublin, Poland.
Krawczyk P; Chair and Department of Pneumology, Oncology and Allergology, Medical University of Lublin, Jaczewskiego 8, 20-090, Lublin, Poland.
Sierocińska-Sawa J; Laboratory of Pathomorphology, Independent Public Clinical Hospital No. 1 in Lublin, ul. Staszica 11, 20-081, Lublin, Poland.
Wallner G; II Chair and Department of General and Gastrointestinal Surgery and Surgical Oncology of the Alimentary Tract, Medical University of Lublin, Staszica 16, 20-080, Lublin, Poland.
Milanowski J; Chair and Department of Pneumology, Oncology and Allergology, Medical University of Lublin, Jaczewskiego 8, 20-090, Lublin, Poland.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2020 Nov 16; Vol. 20 (1), pp. 382. Date of Electronic Publication: 2020 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Genes, erbB-2*
Stomach Neoplasms*/genetics
Stomach Neoplasms*/surgery
Biomarkers, Tumor ; DNA Copy Number Variations ; Esophagogastric Junction ; Gene Amplification ; Humans ; In Situ Hybridization, Fluorescence ; Liquid Biopsy ; Receptor, ErbB-2/genetics
Czasopismo naukowe
Tytuł:
HER2 as a potential biomarker of lymph node metastasis in undifferentiated early gastric cancer.
Autorzy:
Han S; Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea.
Park S; College of Medicine, Gachon University, Incheon, Republic of Korea.; Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, Republic of Korea.
An J; Department of Pathology, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
Yang JY; Department of Surgery, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
Chung JW; Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
Kim YJ; Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
Kim KO; Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
Park DK; Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
Kwon KA; Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
Lee WK; Department of Surgery, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea.
Nam S; College of Medicine, Gachon University, Incheon, Republic of Korea. .; Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, Republic of Korea. .; Department of Life Sciences, Gachon University, Seongnam, Republic of Korea. .; Gachon Advanced Institute of Health Sciences & Technology, Gachon University, Incheon, Republic of Korea. .
Kim JH; Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon, Republic of Korea. .; Gachon Medical Research Institute, Gachon University Gil Medical Center, Incheon, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Mar 24; Vol. 10 (1), pp. 5270. Date of Electronic Publication: 2020 Mar 24.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genes, erbB-2*
Adenocarcinoma/*secondary
Lymphatic Metastasis/*genetics
Neoplasm Proteins/*physiology
Receptor, ErbB-2/*physiology
Stomach Neoplasms/*pathology
Adenocarcinoma/genetics ; Adenocarcinoma/surgery ; Aged ; Biomarkers, Tumor ; Cell Differentiation ; Datasets as Topic ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Lymph Node Excision ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Proteins/biosynthesis ; Neoplasm Proteins/genetics ; Receptor, ErbB-2/biosynthesis ; Receptor, ErbB-2/genetics ; Retrospective Studies ; Stomach Neoplasms/genetics ; Up-Regulation
Czasopismo naukowe
Tytuł:
ErbB1 and ErbB2 overexpression in patients with sinonasal inverted papilloma and inverted papilloma with squamous cell carcinoma in China.
Autorzy:
Li H; Department of Otolaryngology, Eye and ENT Hospital of Fudan University, Shanghai, China.
Hu L; Department of Otolaryngology, Eye and ENT Hospital of Fudan University, Shanghai, China.; Department of Research Centre, Eye and ENT Hospital of Fudan University, Shanghai, China.
Zhang H; Department of Otolaryngology, Eye and ENT Hospital of Fudan University, Shanghai, China.
Wang D; Department of Otolaryngology, Eye and ENT Hospital of Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Acta oto-laryngologica [Acta Otolaryngol] 2019 Dec; Vol. 139 (12), pp. 1104-1111. Date of Electronic Publication: 2019 Sep 26.
Typ publikacji:
Journal Article
MeSH Terms:
Genes, erbB-1*
Genes, erbB-2*
ErbB Receptors/*metabolism
Papilloma, Inverted/*metabolism
Paranasal Sinus Neoplasms/*metabolism
Adult ; Aged ; Case-Control Studies ; China ; Female ; Humans ; Male ; Middle Aged ; Nasal Mucosa/pathology ; Papilloma, Inverted/genetics ; Papilloma, Inverted/pathology ; Paranasal Sinus Neoplasms/genetics ; Paranasal Sinus Neoplasms/pathology ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies